EDAP TMS S.A ROE 2010-2024 | EDAP
Current and historical return on equity (ROE) values for EDAP TMS S.A (EDAP) over the last 10 years. Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
| EDAP TMS S.A ROE - Return on Equity Historical Data | |||
|---|---|---|---|
| Date | TTM Net Income | Shareholder's Equity | Return on Equity |
| 2024-12-31 | $-0.02B | $0.04B | -42.00% |
| 2024-09-30 | $-0.02B | $0.05B | -43.84% |
| 2024-06-30 | $-0.02B | $0.05B | -35.74% |
| 2024-03-31 | $-0.02B | $0.06B | -30.04% |
| 2023-12-31 | $-0.02B | $0.06B | -32.71% |
| 2023-09-30 | $-0.02B | $0.06B | -31.10% |
| 2023-06-30 | $-0.02B | $0.07B | -24.66% |
| 2023-03-31 | $-0.01B | $0.07B | -15.83% |
| 2022-12-31 | $0.00B | $0.08B | -4.60% |
| 2022-09-30 | $0.00B | $0.07B | 6.64% |
| 2022-06-30 | $0.00B | $0.06B | 5.36% |
| 2022-03-31 | $0.00B | $0.06B | 0.00% |
| 2021-12-31 | $0.00B | $0.06B | 1.98% |
| 2021-09-30 | $0.00B | $0.06B | 0.00% |
| 2021-06-30 | $0.00B | $0.06B | 0.00% |
| 2021-03-31 | $0.00B | $0.03B | 4.30% |
| 2020-12-31 | $0.00B | $0.03B | -6.56% |
| 2020-09-30 | $0.00B | $0.03B | -20.00% |
| 2020-06-30 | $0.00B | -12.90% | |
| 2020-03-31 | $0.00B | 12.90% | |
| 2019-12-31 | $0.00B | $0.03B | 25.81% |
| 2019-09-30 | $0.00B | 55.17% | |
| 2019-06-30 | $0.00B | 27.59% | |
| 2019-03-31 | $0.00B | -6.90% | |
| 2018-12-31 | $0.00B | $0.03B | -6.90% |
| 2018-09-30 | $0.00B | -14.04% | |
| 2018-06-30 | $0.00B | $0.03B | -14.04% |
| 2018-03-31 | $0.00B | -21.43% | |
| 2017-12-31 | $0.00B | $0.03B | -7.14% |
| 2017-09-30 | $0.00B | -14.55% | |
| 2017-06-30 | $0.00B | $0.03B | 0.00% |
| 2017-03-31 | $0.01B | 36.36% | |
| 2016-12-31 | $0.01B | $0.03B | 36.36% |
| 2016-09-30 | $0.01B | 109.09% | |
| 2016-06-30 | $0.01B | $0.03B | 54.55% |
| 2016-03-31 | $0.00B | 51.61% | |
| 2015-12-31 | $0.00B | $0.02B | -12.90% |
| 2015-09-30 | $-0.01B | $0.00B | -114.29% |
| 2015-06-30 | $0.00B | $0.02B | 45.71% |
| 2015-03-31 | $0.00B | $0.00B | -45.71% |
| 2014-12-31 | $0.00B | $0.02B | 0.00% |
| 2014-09-30 | $0.00B | 29.63% | |
| 2014-06-30 | $-0.01B | $0.02B | -103.70% |
| 2014-03-31 | $0.00B | 0.00% | |
| 2013-12-31 | $-0.01B | $0.01B | -80.00% |
| 2013-09-30 | $-0.01B | -85.71% | |
| 2013-06-30 | $-0.01B | $0.01B | -71.79% |
| 2013-03-31 | $-0.01B | $0.01B | -97.56% |
| 2012-12-31 | $-0.01B | $0.01B | -66.67% |
| 2012-09-30 | $-0.01B | $0.01B | -64.29% |
| 2012-06-30 | $-0.01B | $0.02B | -48.28% |
| 2012-03-31 | $-0.01B | $0.02B | -43.64% |
| 2011-12-31 | $0.00B | $0.01B | -15.69% |
| 2011-09-30 | $-0.01B | $0.01B | -86.27% |
| 2011-06-30 | $-0.01B | $0.01B | -109.80% |
| 2011-03-31 | $-0.01B | $0.01B | -100.00% |
| 2010-12-31 | $-0.02B | $0.01B | -128.30% |
| 2010-09-30 | $-0.01B | $0.01B | -33.90% |
| 2010-06-30 | $-0.01B | $0.01B | -70.97% |
| 2010-03-31 | $-0.01B | $0.02B | -64.71% |
| 2009-12-31 | $-0.01B | $0.02B | -61.11% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Instruments Manufacturing | $0.051B | $0.069B |
| EDAP TMS S.A. develops, produces, markets and distributes minimally invasive medical devices, primarily for the treatment of urological diseases. They currently produce and market devices for treatment of benign prostate hyperplasia and urinary tract stones. They are also developing a third range of products for minimally invasive destruction of certain types of tumors. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Intuitive Surgical (ISRG) | United States | $171.942B | 78.88 |
| Thermo Fisher Scientific (TMO) | United States | $161.378B | 19.56 |
| Alcon (ALC) | Switzerland | $45.645B | 30.34 |
| Edwards Lifesciences (EW) | United States | $42.050B | 27.30 |
| IDEXX Laboratories (IDXX) | United States | $33.347B | 38.56 |
| DexCom (DXCM) | United States | $26.887B | 41.56 |
| IQVIA Holdings (IQV) | United States | $25.374B | 14.04 |
| STERIS (STE) | Ireland | $21.834B | 24.97 |
| Mettler-Toledo (MTD) | United States | $20.944B | 24.42 |
| Waters (WAT) | United States | $19.099B | 27.04 |
| SONOVA HOLDING (SONVY) | Switzerland | $17.304B | 0.00 |
| Fresenius Medical Care AG KGaA (FMS) | Germany | $13.878B | 14.16 |
| Hologic (HOLX) | United States | $12.916B | 13.94 |
| Sysmex ADR (SSMXY) | Japan | $11.847B | 0.00 |
| Penumbra (PEN) | United States | $10.729B | 96.64 |
| Globus Medical (GMED) | United States | $9.767B | 22.61 |
| Masimo (MASI) | United States | $8.221B | 34.50 |
| Teleflex (TFX) | United States | $6.004B | 9.24 |
| Glaukos (GKOS) | United States | $5.153B | 0.00 |
| Integer Holdings (ITGR) | United States | $4.081B | 22.07 |
| TransMedics (TMDX) | United States | $2.985B | 87.37 |
| PROCEPT BioRobotics (PRCT) | United States | $2.907B | 0.00 |
| Veracyte (VCYT) | United States | $2.427B | 43.86 |
| Nihon Kohden (NHNKY) | Japan | $2.081B | 11.37 |
| LivaNova (LIVN) | United Kingdom | $1.934B | 11.74 |
| Elekta AB (EKTAY) | Sweden | $1.891B | 17.00 |
| Alphatec Holdings (ATEC) | United States | $1.522B | 0.00 |
| Integra LifeSciences Holdings (IART) | United States | $1.222B | 6.18 |
| Pulse Biosciences (PLSE) | United States | $1.193B | 0.00 |
| Tandem Diabetes Care (TNDM) | United States | $1.122B | 0.00 |
| Paragon 28 (FNA) | United States | $1.099B | 0.00 |
| Artivion (AORT) | United States | $0.979B | 91.72 |
| OPKO Health (OPK) | United States | $0.954B | 0.00 |
| AxoGen (AXGN) | United States | $0.690B | 0.00 |
| IRadimed (IRMD) | United States | $0.658B | 34.51 |
| Mesa Laboratories (MLAB) | United States | $0.609B | 13.30 |
| SiBone (SIBN) | United States | $0.588B | 0.00 |
| RxSight (RXST) | United States | $0.584B | 0.00 |
| AVANOS MEDICAL, INC (AVNS) | United States | $0.572B | 9.21 |
| OrthoPediatrics (KIDS) | United States | $0.510B | 0.00 |
| ORTHOFIX MEDICAL INC (OFIX) | United States | $0.508B | 0.00 |
| Beta Bionics (BBNX) | United States | $0.483B | 0.00 |
| Treace Medical Concepts (TMCI) | United States | $0.406B | 0.00 |
| Delcath Systems (DCTH) | United States | $0.389B | 0.00 |
| AngioDynamics (ANGO) | United States | $0.387B | 0.00 |
| NeuroPace (NPCE) | United States | $0.351B | 0.00 |
| Pacific Biosciences Of California (PACB) | United States | $0.348B | 0.00 |
| ClearPoint Neuro (CLPT) | United States | $0.342B | 0.00 |
| Tactile Systems Technology (TCMD) | United States | $0.315B | 16.87 |
| Semler Scientific (SMLR) | United States | $0.312B | 6.62 |
| Neuronetics (STIM) | United States | $0.247B | 0.00 |
| Inogen (INGN) | United States | $0.183B | 0.00 |
| Alpha Tau Medical (DRTS) | Israel | $0.181B | 0.00 |
| 908 Devices (MASS) | United States | $0.168B | 0.00 |
| Spectral Diagnostics (EDTXF) | Canada | $0.165B | 0.00 |
| LENSAR (LNSR) | United States | $0.164B | 0.00 |
| CVRx (CVRX) | United States | $0.163B | 0.00 |
| Accuray (ARAY) | United States | $0.152B | 0.00 |
| Sight Sciences (SGHT) | United States | $0.137B | 0.00 |
| Lucid Diagnostics (LUCD) | United States | $0.110B | 0.00 |
| KORU Medical Systems (KRMD) | United States | $0.104B | 0.00 |
| Rapid Micro Biosystems (RPID) | United States | $0.104B | 0.00 |
| Anteris Technologies Global (AVR) | Australia | $0.104B | 0.00 |
| Monogram Orthopaedics (MGRM) | United States | $0.095B | 0.00 |
| Microbot Medical (MBOT) | United States | $0.087B | 0.00 |
| Atossa Genetics (ATOS) | United States | $0.080B | 0.00 |
| InspireMD (NSPR) | Israel | $0.079B | 0.00 |
| Sensus Healthcare (SRTS) | United States | $0.076B | 11.48 |
| Hyperfine (HYPR) | United States | $0.054B | 0.00 |
| Positron (POSC) | United States | $0.051B | 0.00 |
| EnVVeno Medical (NVNO) | United States | $0.043B | 0.00 |
| Baird Medical Investment Holdings (BDMD) | $0.037B | 0.00 | |
| Vicarious Surgical (RBOT) | United States | $0.032B | 0.00 |
| Spectral AI (MDAI) | United States | $0.031B | 0.00 |
| DarioHealth (DRIO) | United States | $0.031B | 0.00 |
| Precision Optics (POCI) | United States | $0.030B | 0.00 |
| Envoy Medical (COCH) | United States | $0.029B | 0.00 |
| Adagio Medical Holdings (ADGM) | United States | $0.027B | 0.00 |
| NexGel (NXGL) | United States | $0.022B | 0.00 |
| Accelerate Diagnostics (AXDX) | United States | $0.014B | 0.00 |
| PAVmed (PAVM) | United States | $0.012B | 0.00 |
| Ekso Bionics Holdings (EKSO) | United States | $0.012B | 0.00 |
| Biosig Technologies (BSGM) | United States | $0.010B | 0.00 |
| Inspira Technologies OXY B.H.N (IINN) | Israel | $0.007B | 0.00 |
| Tenon Medical (TNON) | United States | $0.007B | 0.00 |
| WORK Medical Technology Group (WOK) | China | $0.006B | 0.00 |
| Nanovibronix (NAOV) | United States | $0.005B | 0.00 |
| Autonomix Medical (AMIX) | United States | $0.005B | 0.00 |
| SINTX TECHNOLOGIES, INC (SINT) | United States | $0.004B | 0.00 |
| Venus Concept (VERO) | Canada | $0.004B | 0.00 |
| Nuwellis (NUWE) | United States | $0.004B | 0.00 |
| Check-Cap (CHEK) | Israel | $0.004B | 0.00 |
| ReShape Lifesciences (RSLS) | United States | $0.003B | 0.00 |
| ENDRA Life Sciences (NDRA) | United States | $0.002B | 0.00 |
| Helius Medical Technologies (HSDT) | United States | $0.002B | 0.00 |
| Avinger (AVGR) | United States | $0.002B | 0.00 |
| Bluejay Diagnostics (BJDX) | United States | $0.001B | 0.00 |
| Longview Acquisition II (LGV) | United States | $0.000B | 0.00 |
| Spinal Elements Holdings (SPEL) | United States | $0.000B | 0.00 |